%%subject%%

Children's Hospital Los Angeles, Thermo Fisher to Develop NGS Pediatric Cancer Test Panel

Email not displaying correctly?
View it in your browser.



	February 23, 2016

ACQUISITIONS
A Big Deal for Big Data: IBM to Acquire Truven for $2.6 Billion
By Stephanie Murg, Managing Director, G2 Intelligence
Less than a year after launching its Watson Health unit, IBM (Armonk, N.Y.) has announced a fourth major health data-related acquisition…
Read More

TECHNOLOGY
Portable Sequencer Provides Real-Time Outbreak Surveillance
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Real-time genomic surveillance is possible in resource-limited settings to monitor infectious disease outbreaks, according to…
Read More

DOJ
Labs Safe, but Marketing Company and Referring Physician Get In Trouble for Kickbacks
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Once again, payments to physicians to induce referrals of lab tests has led to government enforcement efforts—but this time, the labs were not involved and not charged with…
Read More

DEALS
Children's Hospital Los Angeles, Thermo Fisher to Develop NGS Pediatric Cancer Test Panel
By Ron Shinkman, Editor, Laboratory Industry Report
Children's Hospital Los Angeles (CHLA) has entered into a pact with Thermo Fisher Scientific to develop a panel of next-generation sequencing tests specifically for…
Read More

Follow on Twitter | Forward to a Friend

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Unsubscribe